MEDTOX SCIENTIFIC INC 4
4 · MEDTOX SCIENTIFIC INC · Filed Aug 1, 2012
Insider Transaction Report
Form 4
WIERSMA KEVIN J
V.P., COO - Labs, and CFO
Transactions
- Disposition to Issuer
Common Stock
2012-07-31$27.00/sh−4,165$112,455→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-07-31$27.00/sh−15,000$405,000→ 0 totalExercise: $4.41From: 2003-01-01Exp: 2013-01-01→ Common Stock (15,000 underlying) - Disposition to Issuer
Common Stock
2012-07-31$27.00/sh−86,917$2,346,759→ 34,210 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-07-31$27.00/sh−30,000$810,000→ 0 totalExercise: $3.70From: 2003-09-11Exp: 2013-12-31→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2012-07-31$27.00/sh−30,045$811,215→ 4,165 total
Footnotes (5)
- [F1]Disposition is exempt under Rule 16(b)(3)
- [F2]Disposed of pursuant to merger agreement between issuer and Laboratory Corporation of America Holdings in exchange for $27.00 per share cash.
- [F3]Attributable to non-qualified deferred compensation plan.
- [F4]This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $23.30, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.
- [F5]This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $25.5933, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.